Met Life Investment Management, LLC X4 Pharmaceuticals, Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.58 - $1.47 $0 - $0
0 New
0 $0
Q3 2023

May 09, 2024
BUY
$1.03 - $2.02 $67,383 - $132,150
65,421 New
65,421 $71,000
Q2 2023

Apr 29, 2024
BUY
$0.82 - $2.49 $53,645 - $162,898
65,421 New
65,421 $126,000
Q2 2023

Aug 10, 2023
BUY
$0.82 - $2.49 $53,645 - $162,898
65,421 New
65,421 $126,000

Others Institutions Holding XFOR

# of Institutions
103
Shares Held
99.9M
Call Options Held
213K
Put Options Held
50.6K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $55.6M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email